ELTP Stock Alert 08/17/2014 11:23:12 $ELTP
ah, so the answer appears to be zero!!! Thanks. Useful information. The only company in the world than can do ADT. LOL LOL
Doesn't matter- Elite's owns 3 US patents and 1 Canadain with more coming. Only thing that matters is that Nasrat launch the abuse resistant opioids. And Nasrat says Elite is still on schedule to file it's first NDA by the end if this year.
Quote:
Elite remains on track to file its first abuse-deterrent opioid product, ELI-200, by the end of calendar 2014.
no no no. I am asking if ANY elite current employees hold ANY patents.
Then put 2 and 2 together.... If the WORST CASE SCENARIO of an independent valuation has us at .40 and best case 2.75, and we are BELOW .40... duh. Undervalued.
It's always the same pattern. Straw man arguments followed by an attempt to discredit the data when shown. If Nasrat had released the evaluating firm, then their rep and credibility would be attacked next.
Been here since 2011!! never posted before, or maybe once. Either way, I read every post of this board as I am long on Elite and have been averaging up since last August. We already know most of the answers to the questions that are supposed to be asked on the tomorrows CC. If one would read the latest filing, and no I will not take the time to copy and paste it, it is all there to read, we are at 733 million shares outstanding fully diluted. LPC has purchased shares at 0.37 within the last quarter. Since June 30th, it is noted that LPC has again been sold more shares...I do believe it to be around 6 million shares on August 6th..I don't recall the number off hand. Clearly these shares will be at a lesser value than 0.37 since we have been under that pps since late July. All of this means what? Nothing, even if Elite issues all shares authorized at 995 million in order to get its ART products approved, so be it. We are still very undervalued. I have watched Elite's market cap grow tenfold since I first heard about the company. I could care less about a spike to 0,97. Sure would have been nice to sell at those levels...why not. But I am certainly not giving my shares back at 0.34. Lots of noise on this board, and perhaps i'm adding to it today, but read the entire filing, all will be well. Its a pharma company, and as Diane said to me during out last conversation, these things don't happen over night. Good luck to all, the goal is to make money. So if traders make good on their decisions, good on them too.
**** Elite Pharmaceuticals Conference Call Questions ****
Shareholders participating in the Conference Call are typically allowed to ask 1 or 2 questions following the company's prepared statements.
To make the most of this Q&A opportunity with ELTP management, suggest that we come up with a list to share of top questions to ask:
(Copy/paste and add your question(s) at the end of the latest posted list)
1. Clinical Trials
a. When can we expect Lifetree abuse liability results?
b. How long do you expect these trials to last?
c. How many products are tested at a time in these studies?
d. Is the plan to file upon successful results?
2. Please explain the purpose for the upcoming meeting in October with the FDA. Best case and worst case scenario.
3. With so much going on will Analyst be reassess-updating last Falls value of Elite for future negotiations?
6. Lincoln Park Capital (LPC) Securities Funding
a. How many have been placed with LPC exclusive of the free shares?
b. How much money was generated for the shares?
c. How much of the money has been spent?
d. What was it used on?
7. 2 FDA applications ... what info can we get? How long have they been in the system?
8. 11 ANDA's for site transfer, what's going on?
9. Any plans for Eli-154?
10. What's the next step for Eli-201?
11. What's going on with the three drugs in Scale up?
12. Any generics moving up the ladder to commercialization?
13. Given the share price hovering at the “worst case” scenario, and far below the 2.10-2.75 levels that were indicated
as the more reasonable valuation range at that time, why are you comfortable with the valuation as reflective of Elite’s future?
14. In July, the FDA approved Purdue's Targiniq ER with labeling describing the product's abuse-deterrent properties. Is ELTP's ART more effective than Purdue's? If so, is it likely that the FDA will also approve ELTP's ART products?
15. What is ELTP expecting from the FDA by filing the INDs for ELI-200 and ELI-202?
16. Given the information in the 10-Q regarding the expansion of the Northvale facilities... Does this mean ELTP could potentially manufacture and distribute all of the ART drugs without a partner?
17. I understand we had an agreement with Epic for 8 drugs where we get a 15% profit split. I also understand that we are no longer proceeding with the last 7 drugs. However, the first and only drug has been filed with the FDA for 3 1/2 years now and we haven't heard anything. Do you have any updates on this?
LMAO - worrisome - Nasrat said he welcomes it as Pfizer will educate doctors and hospitals about the pharmacologic approach to abuse deterent technology/opioids.
What's really funny by using the same comparison Ian Read wasn't the one who invented Embeda. Doesn't matter one bit- Nasrat is bringing Elite's ART to market. At this point, that's all that matters.
TELL me about it !!!
They would have to have the HIGHEST bid.
Nasrat not giving this one away.
poison pill in place
ELTP
What product? Oh yes it is in the pipeline.
To use a basketball analogy it is like at team getting ahead 100 to 10 in the first three quarters then losing the game in the last quarter because it ran out of steam and that is exactly what happened to Elite. I am sure in many minds it is looked at as a pump and dump and that is exactly what it is if it can gain 95% and promptly lose 87% of the gain. There is more to just going up from .068 to .34. The disappointed investors that it has left behind means a lot to the future of Elite especially after it is piled upon the baggage it brought along from prior years. The fact that CEO hyped the stock at $4 to $5 didn't help and even worst his use of valuations of $2.10 to $2.75 with a worse case situation of $.40 was a disaster since Elite has been below the worse case scenario for some time.
Funny when Nasrat became CEO about a year ago the PPS was .068. Looks like the PPS has moved up to me.
Elite Laboratories - Withdrawal of Petition
Click on PDF attachment for Jerry Treppel letter and FedEx label.
http://www.regulations.gov/#!documentDetail;D...-0694-0003
As per Elite Laboratories, Inc. discussion with OGD on July 25, 2013, Elite hereby is withdrawing
it's Citizen Petition sent May 31, 2013 — Docket Number FDA2013-P-0694.
Northvale, New Jersey, Friday, June 21, 2013:
Jerry Treppel, Chairman and CEO of Elite commented, "It has been a remarkable year for Elite. We launched new products, substantially increased our revenues, and lowered our operating losses. Most importantly, I can now tell you that we expect our first commercially scaled-up, abuse-resistant opioid product to enter human pilot studies later this year. We have also conducted work on another abuse-resistant opioid product. We have also received FDA feedback on clinical protocols for the extended release brompheniramine product and have filed a Citizen Petition regarding the extended release brompheniramine/pseudoephedrine product, which, if successful, would put this product in a position to also begin clinical trials and eventually secure approvals for bringing these products on to the market.
http://www.elitepharma.com/product_pipeline.asp
Brompheniramine
Maleate with
Pseudoephedrine HCl
24 hour product
Scale-up
Owned by Elite
That would make a lot of sense wouldn't it? You never know!
Pfizer has a string of recent "bad decision" acquisitions while currently facing several lawsuits. AstraZeneca decision to reject Pfizer's +$119 billion acquisition is how the industry now views Pfizer terrible reputation!
What new embeda trial? There was no such thing
Why in the world would they buy elite?
ah, so the answer appears to be zero!!! Thanks. Useful information. The only company in the world than can do ADT. LOL LOL
Doesn't matter- Elite's owns 3 US patents and 1 Canadain with more coming. Only thing that matters is that Nasrat launch the abuse resistant opioids. And Nasrat says Elite is still on schedule to file it's first NDA by the end if this year.
Quote:
Elite remains on track to file its first abuse-deterrent opioid product, ELI-200, by the end of calendar 2014.
no no no. I am asking if ANY elite current employees hold ANY patents.
Then put 2 and 2 together.... If the WORST CASE SCENARIO of an independent valuation has us at .40 and best case 2.75, and we are BELOW .40... duh. Undervalued.
It's always the same pattern. Straw man arguments followed by an attempt to discredit the data when shown. If Nasrat had released the evaluating firm, then their rep and credibility would be attacked next.
Been here since 2011!! never posted before, or maybe once. Either way, I read every post of this board as I am long on Elite and have been averaging up since last August. We already know most of the answers to the questions that are supposed to be asked on the tomorrows CC. If one would read the latest filing, and no I will not take the time to copy and paste it, it is all there to read, we are at 733 million shares outstanding fully diluted. LPC has purchased shares at 0.37 within the last quarter. Since June 30th, it is noted that LPC has again been sold more shares...I do believe it to be around 6 million shares on August 6th..I don't recall the number off hand. Clearly these shares will be at a lesser value than 0.37 since we have been under that pps since late July. All of this means what? Nothing, even if Elite issues all shares authorized at 995 million in order to get its ART products approved, so be it. We are still very undervalued. I have watched Elite's market cap grow tenfold since I first heard about the company. I could care less about a spike to 0,97. Sure would have been nice to sell at those levels...why not. But I am certainly not giving my shares back at 0.34. Lots of noise on this board, and perhaps i'm adding to it today, but read the entire filing, all will be well. Its a pharma company, and as Diane said to me during out last conversation, these things don't happen over night. Good luck to all, the goal is to make money. So if traders make good on their decisions, good on them too.
**** Elite Pharmaceuticals Conference Call Questions ****
Shareholders participating in the Conference Call are typically allowed to ask 1 or 2 questions following the company's prepared statements.
To make the most of this Q&A opportunity with ELTP management, suggest that we come up with a list to share of top questions to ask:
(Copy/paste and add your question(s) at the end of the latest posted list)
1. Clinical Trials
a. When can we expect Lifetree abuse liability results?
b. How long do you expect these trials to last?
c. How many products are tested at a time in these studies?
d. Is the plan to file upon successful results?
2. Please explain the purpose for the upcoming meeting in October with the FDA. Best case and worst case scenario.
3. With so much going on will Analyst be reassess-updating last Falls value of Elite for future negotiations?
6. Lincoln Park Capital (LPC) Securities Funding
a. How many have been placed with LPC exclusive of the free shares?
b. How much money was generated for the shares?
c. How much of the money has been spent?
d. What was it used on?
7. 2 FDA applications ... what info can we get? How long have they been in the system?
8. 11 ANDA's for site transfer, what's going on?
9. Any plans for Eli-154?
10. What's the next step for Eli-201?
11. What's going on with the three drugs in Scale up?
12. Any generics moving up the ladder to commercialization?
13. Given the share price hovering at the “worst case” scenario, and far below the 2.10-2.75 levels that were indicated
as the more reasonable valuation range at that time, why are you comfortable with the valuation as reflective of Elite’s future?
14. In July, the FDA approved Purdue's Targiniq ER with labeling describing the product's abuse-deterrent properties. Is ELTP's ART more effective than Purdue's? If so, is it likely that the FDA will also approve ELTP's ART products?
15. What is ELTP expecting from the FDA by filing the INDs for ELI-200 and ELI-202?
16. Given the information in the 10-Q regarding the expansion of the Northvale facilities... Does this mean ELTP could potentially manufacture and distribute all of the ART drugs without a partner?
17. I understand we had an agreement with Epic for 8 drugs where we get a 15% profit split. I also understand that we are no longer proceeding with the last 7 drugs. However, the first and only drug has been filed with the FDA for 3 1/2 years now and we haven't heard anything. Do you have any updates on this?
LMAO - worrisome - Nasrat said he welcomes it as Pfizer will educate doctors and hospitals about the pharmacologic approach to abuse deterent technology/opioids.
What's really funny by using the same comparison Ian Read wasn't the one who invented Embeda. Doesn't matter one bit- Nasrat is bringing Elite's ART to market. At this point, that's all that matters.
TELL me about it !!!
They would have to have the HIGHEST bid.
Nasrat not giving this one away.
poison pill in place
ELTP
What product? Oh yes it is in the pipeline.
To use a basketball analogy it is like at team getting ahead 100 to 10 in the first three quarters then losing the game in the last quarter because it ran out of steam and that is exactly what happened to Elite. I am sure in many minds it is looked at as a pump and dump and that is exactly what it is if it can gain 95% and promptly lose 87% of the gain. There is more to just going up from .068 to .34. The disappointed investors that it has left behind means a lot to the future of Elite especially after it is piled upon the baggage it brought along from prior years. The fact that CEO hyped the stock at $4 to $5 didn't help and even worst his use of valuations of $2.10 to $2.75 with a worse case situation of $.40 was a disaster since Elite has been below the worse case scenario for some time.
Funny when Nasrat became CEO about a year ago the PPS was .068. Looks like the PPS has moved up to me.
Elite Laboratories - Withdrawal of Petition
Click on PDF attachment for Jerry Treppel letter and FedEx label.
http://www.regulations.gov/#!documentDetail;D...-0694-0003
As per Elite Laboratories, Inc. discussion with OGD on July 25, 2013, Elite hereby is withdrawing
it's Citizen Petition sent May 31, 2013 — Docket Number FDA2013-P-0694.
Northvale, New Jersey, Friday, June 21, 2013:
Jerry Treppel, Chairman and CEO of Elite commented, "It has been a remarkable year for Elite. We launched new products, substantially increased our revenues, and lowered our operating losses. Most importantly, I can now tell you that we expect our first commercially scaled-up, abuse-resistant opioid product to enter human pilot studies later this year. We have also conducted work on another abuse-resistant opioid product. We have also received FDA feedback on clinical protocols for the extended release brompheniramine product and have filed a Citizen Petition regarding the extended release brompheniramine/pseudoephedrine product, which, if successful, would put this product in a position to also begin clinical trials and eventually secure approvals for bringing these products on to the market.
http://www.elitepharma.com/product_pipeline.asp
Brompheniramine
Maleate with
Pseudoephedrine HCl
24 hour product
Scale-up
Owned by Elite
That would make a lot of sense wouldn't it? You never know!
Pfizer has a string of recent "bad decision" acquisitions while currently facing several lawsuits. AstraZeneca decision to reject Pfizer's +$119 billion acquisition is how the industry now views Pfizer terrible reputation!
What new embeda trial? There was no such thing
Why in the world would they buy elite?
